Our results suggest that tDCS in MCI patients who are also APOE ε4 carriers, and thus at increased risk for AD, may strengthen SN-CEN inter-network FC, potentially aiding in the preservation of cognitive function. This evidence concerns the gene APOE and Alzheimer disease.